Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seiya Okuda

Showing results (11-20 of 116) with videos related to

Pageof 12
Sort By:
Current Pharmaceutical Design|July 13, 2013
Role of AGEs-RAGE system in cardiovascular diseaseKei Fukami, Sho-Ichi Yamagishi, Seiya Okuda
The Journal of Laboratory and Clinical Medicine|October 22, 2002
Different effects of 22-oxacalcitriol and calcitriol on the course of experimental chronic renal failureToru Sanai, Masanori Tokumoto, Tadashi Hirano, et al.
Renal Failure|December 15, 2005
Effects of thyroid function on the course of experimental chronic renal failure in ratsToru Sanai, Tadashi Hirano, Masaharu Nagata, et al.
Current Opinion in Nephrology and Hypertension|December 4, 2014
Receptor for advanced glycation endproducts and progressive kidney diseaseKei Fukami, Kensei Taguchi, Sho-ichi Yamagishi, et al.
Current Drug Targets|August 21, 2007
Molecular mechanisms of diabetic nephropathy and its therapeutic interventionSho-ichi Yamagishi, Kei Fukami, Seiji Ueda, et al.
Current Pharmaceutical Design|July 13, 2013
Role of asymmetric dimethylarginine in cardiorenal syndromeSeiji Ueda, Sho-Ichi Yamagishi, Miyuki Yokoro, et al.
Current Pharmaceutical Design|May 14, 2008
Role of AGEs in diabetic nephropathyKei Fukami, Sho-Ichi Yamagishi, Seiji Ueda, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 15, 2012
[Chronic kidney disease (CKD)--recent progress. Topics: VI. Chronic kidney disease (CKD) and associated disorders; 1. Chronic kidney disease and cardiovascular disease]Seiji Ueda, Sho-ichi Yamagishi, Nana Obara, et al.
Nephrology (Carlton, Vic.)|November 13, 2007
Asymmetric dimethylarginine may be a missing link between cardiovascular disease and chronic kidney diseaseSeiji Ueda, Sho-Ichi Yamagishi, Yusuke Kaida, et al.
Journal of the American Society of Nephrology : JASN|September 27, 2000
Role of lipoprotein (a) and TGF-beta 1 in atherosclerosis of hemodialysis patientsMasahisa Fujisawa, Reiko Haramaki, Hiroshi Miyazaki, et al.
Pageof 12

Showing results (11-20 of 116) with videos related to

Sort By:
Pageof 12
Current Pharmaceutical Design|July 13, 2013
Role of AGEs-RAGE system in cardiovascular diseaseKei Fukami, Sho-Ichi Yamagishi, Seiya Okuda
The Journal of Laboratory and Clinical Medicine|October 22, 2002
Different effects of 22-oxacalcitriol and calcitriol on the course of experimental chronic renal failureToru Sanai, Masanori Tokumoto, Tadashi Hirano, et al.
Renal Failure|December 15, 2005
Effects of thyroid function on the course of experimental chronic renal failure in ratsToru Sanai, Tadashi Hirano, Masaharu Nagata, et al.
Current Opinion in Nephrology and Hypertension|December 4, 2014
Receptor for advanced glycation endproducts and progressive kidney diseaseKei Fukami, Kensei Taguchi, Sho-ichi Yamagishi, et al.
Current Drug Targets|August 21, 2007
Molecular mechanisms of diabetic nephropathy and its therapeutic interventionSho-ichi Yamagishi, Kei Fukami, Seiji Ueda, et al.
Current Pharmaceutical Design|July 13, 2013
Role of asymmetric dimethylarginine in cardiorenal syndromeSeiji Ueda, Sho-Ichi Yamagishi, Miyuki Yokoro, et al.
Current Pharmaceutical Design|May 14, 2008
Role of AGEs in diabetic nephropathyKei Fukami, Sho-Ichi Yamagishi, Seiji Ueda, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 15, 2012
[Chronic kidney disease (CKD)--recent progress. Topics: VI. Chronic kidney disease (CKD) and associated disorders; 1. Chronic kidney disease and cardiovascular disease]Seiji Ueda, Sho-ichi Yamagishi, Nana Obara, et al.
Nephrology (Carlton, Vic.)|November 13, 2007
Asymmetric dimethylarginine may be a missing link between cardiovascular disease and chronic kidney diseaseSeiji Ueda, Sho-Ichi Yamagishi, Yusuke Kaida, et al.
Journal of the American Society of Nephrology : JASN|September 27, 2000
Role of lipoprotein (a) and TGF-beta 1 in atherosclerosis of hemodialysis patientsMasahisa Fujisawa, Reiko Haramaki, Hiroshi Miyazaki, et al.
Pageof 12